|
JP2008029353A
|
|
Method for producing anti-human soluble fibrin monoclonal antibody
|
|
JP2007295935A
|
|
Quantitative determination method of cholesterol
|
|
JP2008032586A
|
|
Holding sheet body for stick-like clinical examination tool
|
|
JP2007029094A
|
|
Method for stabilization of leuco dye
|
|
JP2007023384A
|
|
Method for adjusting diameter of colloidal gold particle and colloidal gold solution
|
|
JP2007322187A
|
|
Method for judging risk of restenosis development
|
|
JP2006246893A
|
|
Method of lipid assay and reagent for use therefor
|
|
WO2006093224A1
|
|
Immunoassay method and reagent therefor
|
|
CA2591872A1
|
|
Reagent for assaying antigen and method of assaying antigen
|
|
US2009215035A1
|
|
Method of assessing cancerous conditions and reagent for detecting gene product to be used in the method
|
|
WO2006043387A1
|
|
Immunological inspection method of specimen and inspection instrument for use therein
|
|
US2008199847A1
|
|
Method for Predicting the Metabolism of Drug in Human Liver and Liver Function
|
|
WO2006019105A1
|
|
Fluorescent labeling agents
|
|
JP2005298521A
|
|
Monoclonal antibody and immunological measurement method therewith
|
|
AU2005202380A1
|
|
Method of pretreatment of sample for quantitating cholesterol and method for quantitating cholesterol in specific lipoproteins by using the same
|
|
AU2005221996A1
|
|
Method of measuring glycated protein
|
|
US2008241816A1
|
|
Method for Stabilizing Oxidizable Color Developing Reagent
|
|
WO2005085846A1
|
|
Diagnostic for ischemic heart disease risk group
|
|
EP1717356A1
|
|
Dast twin crystal, process for producing the same and use thereof
|
|
JP2006160693A
|
|
Method for producing optically active amino acid amide
|
